- 专利标题: Methods of using humanized FCγR mice to assay Fc regions
-
申请号: US17241763申请日: 2021-04-27
-
公开(公告)号: US12036288B2公开(公告)日: 2024-07-16
- 发明人: Lynn MacDonald , Naxin Tu , Cagan Gurer , Sean Stevens , Andrew J. Murphy
- 申请人: Regeneron Pharmaceuticals, Inc.
- 申请人地址: US NY Tarrytown
- 专利权人: Regeneron Pharmaceuticals, Inc.
- 当前专利权人: Regeneron Pharmaceuticals, Inc.
- 当前专利权人地址: US NY Tarrytown
- 代理机构: Foley Hoag LLP
- 代理商 Brendan T. Jones; Tracy L. Vrablik
- 分案原申请号: US13466225 2012.05.08
- 主分类号: G01N33/00
- IPC分类号: G01N33/00 ; A01K67/0276 ; A01K67/0278 ; A61K49/00 ; C07K14/735 ; G01N33/50 ; A01K67/027
摘要:
Genetically modified non-human animals and methods and compositions for making and using them are provided, wherein the genetic modification comprises a deletion of the endogenous low affinity FcγR locus, and wherein the mouse is capable of expressing a functional FcRγ-chain. Genetically modified mice are described, including mice that express low affinity human FcγR genes from the endogenous FcγR locus, and wherein the mice comprise a functional FcRγ-chain. Genetically modified mice that express up to five low affinity human FcγR genes on accessory cells of the host immune system are provided.
公开/授权文献
信息查询